<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>25</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Construction of an Adenovirus Vaccine Expressing the Cross-reactive Antigen AMA1 for Neospora caninum and Toxoplasma gondii and Its Immune Response in an Animal Model</title>
    <FirstPage>235</FirstPage>
    <LastPage>243</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Lijun</FirstName>
        <LastName>JIA</LastName>
        <affiliation locale="en_US">Dept. of Veterinary Medicine, Agricultural College of Yanbian University, Yanji, Jilin 133000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Huanping</FirstName>
        <LastName>GUO</LastName>
        <affiliation locale="en_US">National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan</affiliation>
      </Author>
      <Author>
        <FirstName>Mingming</FirstName>
        <LastName>LIU</LastName>
        <affiliation locale="en_US">National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan</affiliation>
      </Author>
      <Author>
        <FirstName>Yang</FirstName>
        <LastName>GAO</LastName>
        <affiliation locale="en_US">National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan</affiliation>
      </Author>
      <Author>
        <FirstName>Lei</FirstName>
        <LastName>ZHANG</LastName>
        <affiliation locale="en_US">Dept. of Veterinary Medicine, Agricultural College of Yanbian University, Yanji, Jilin 133000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hang</FirstName>
        <LastName>LI</LastName>
        <affiliation locale="en_US">Dept. of Veterinary Medicine, Agricultural College of Yanbian University, Yanji, Jilin 133000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Suzhu</FirstName>
        <LastName>XIE</LastName>
        <affiliation locale="en_US">Dept. of Veterinary Medicine, Agricultural College of Yanbian University, Yanji, Jilin 133000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ningning</FirstName>
        <LastName>ZHANG</LastName>
        <affiliation locale="en_US">Dept. of Veterinary Medicine, Agricultural College of Yanbian University, Yanji, Jilin 133000, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>06</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: We aimed to construct an adenovirus expressing a cross-reactive fragment of the apical membrane antigen 1 (AMA1) antigen and evaluated the concomitant immune response in BABL/c mice, allowing protection against N. caninum and T. gondii infection.

Methods: The study was conducted in Agricultural College of Yanbian University, Yanji, Jilin, China In 2015-2016. Primers were designed using the AMA1 gene sequences of N. caninum (AB265823.1) and T. gondii (AF010264.1). After linearization of the plasmid ADV4-NcAMA1 and the framework plasmid pacAd5, a total of 293T cells were co-transfected and Ad5-NcAMA1 recombinant adenovirus were packed. BALB/c mice were inoculated. Simultaneously serum IgG antibody levels and IFN-&#x3B3;and IL-4 cytokine levels were determined by ELISA. After immunization three times in two weeks, each group of BABL/c mice were divided into two groups, respectively given intraperitoneal inoculation by the Neospora tachyzoite and Toxoplasma tachyzoite. Then we observed the clinical symptoms and statistical survival rate of mice.

Results: The level of IgG in BABL/c mice immunized with Ad5-NcAMA1 was significantly increased when compared with that of pVAX1-NcAMA1 and PBS groups (P&lt;0.01). At the same time, the cytokine levels of IFN-&#x3B3; and IL-4 were also higher in the Ad4-NcAMA1 group than in the control groups (P&lt;0.01). Moreover, BABL/c mice immunized with Ad5-NcAMA1, pVAX1-NcAMA1, and PBS showed survival rates of 75%, 45% and 20% after N. caninum infection, and 45%, 10% and 0% after T. gondii infection, respectively.

Conclusion: The adenovirus vaccineAd5-NcAMA1 could provide protective immunity against N. caninum and T. gondii infection.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/2206</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/2206/831</pdf_url>
  </Article>
</Articles>
